Mereo Biopharma Group PLC (NASDAQ:MREO)
| 2.06 Delayed Data As of Dec 08 |  +0.05 / +2.49%Today’s Change | 0.49 Today|||52-Week Range 2.39 | +174.67% Year-to-Date |
Latest MREO News | Press Releases
No recent news for Mereo Biopharma Group PLC.
Today’s Trading
| Previous close | 2.01 |
| Today’s open | 2.02 |
| Day’s range | 2.00 - 2.08 |
| Volume | 8,027 |
| Average volume (3 months) | 1,129,005 |
| Market cap | $311.3M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -332.89% |
| Earnings growth (this year) | +46.10% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TVTXTravere Therapeutics... | -0.01 | -0.12% |
| HRTXHeron Therapeutics I... | +0.08 | +5.32% |
| CRXMGene Biotherapeutics... | 0.00 | 0.00% |
| --Lattice Biologics Lt... | 0.00 | 0.00% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 27, 2024 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$42.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
